Topolog
View all posts »Antiplatelet therapy: A step forward with individualized medicine
Sep 22, 2009 10:30 EDT-
6Comments
-
Read later
The Scripps clinic and health system is announcing at TCT this week routine genotyping of all patients undergoing stenting after concluding that this data is vital in selecting antiplatelet therapy. What are your thoughts? How do you follow patients who take clopidogrel and have shown a potential increased risk for stent thrombosis or other events?
See:
Your comments
|
||||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!













